{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T08:43:38Z","timestamp":1768812218718,"version":"3.49.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":402,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1038\/mt.2015.110","type":"journal-article","created":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T11:21:16Z","timestamp":1434626476000},"page":"1497-1506","source":"Crossref","is-referenced-by-count":35,"title":["Mesenchymal Stromal Cells for Linked Delivery of Oncolytic and Apoptotic Adenoviruses to Non-small-cell Lung Cancers"],"prefix":"10.1016","volume":"23","author":[{"given":"Valentina","family":"Hoyos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Del Bufalo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Yagyu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miki","family":"Ando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianpietro","family":"Dotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Bouchier-Hayes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramon","family":"Alemany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm K","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2015.110_bib1","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nm0697-639","article-title":"ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents","volume":"3","author":"Heise","year":"1997","journal-title":"Nat Med"},{"key":"10.1038\/mt.2015.110_bib2","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/sj.cgt.7700539","article-title":"Intravascular adenoviral agents in cancer patients: lessons from clinical trials","volume":"9","author":"Reid","year":"2002","journal-title":"Cancer Gene Ther"},{"key":"10.1038\/mt.2015.110_bib3","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/nrc1750","article-title":"Recent progress in the battle between oncolytic viruses and tumours","volume":"5","author":"Parato","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/mt.2015.110_bib4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/ncponc0736","article-title":"Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress","volume":"4","author":"Liu","year":"2007","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1038\/mt.2015.110_bib5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/hum.1997.8.1-37","article-title":"Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration","volume":"8","author":"Worgall","year":"1997","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2015.110_bib6","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/mt.2008.70","article-title":"Translation of targeted oncolytic virotherapeutics from the lab into the clinic, and back again: a high-value iterative loop","volume":"16","author":"Liu","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.110_bib7","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/cgt.2014.53","article-title":"Bortezomib sensitizes non-small cell lung cancer to mesenchymal stromal cell-delivered inducible caspase-9-mediated cytotoxicity","volume":"21","author":"Ando","year":"2014","journal-title":"Cancer Gene Ther"},{"key":"10.1038\/mt.2015.110_bib8","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/cgt.2010.4","article-title":"Treatment of metastatic neuroblastoma with systemic oncolytic virotherapy delivered by autologous mesenchymal stem cells: an exploratory study","volume":"17","author":"Garc\u00eda-Castro","year":"2010","journal-title":"Cancer Gene Ther"},{"key":"10.1038\/mt.2015.110_bib9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2174\/157488808783489462","article-title":"Mesenchymal stem cells: an emerging tool for cancer targeting and therapy","volume":"3","author":"Fritz","year":"2008","journal-title":"Curr Stem Cell Res Ther"},{"key":"10.1038\/mt.2015.110_bib10","doi-asserted-by":"crossref","first-page":"8862","DOI":"10.1158\/0008-5472.CAN-09-1912","article-title":"Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles","volume":"69","author":"Loebinger","year":"2009","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2015.110_bib11","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1089\/scd.2008.0253","article-title":"Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect","volume":"18","author":"Fischer","year":"2009","journal-title":"Stem Cells Dev"},{"key":"10.1038\/mt.2015.110_bib12","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1038\/mt.2010.173","article-title":"Minimal RB-responsive E1A promoter modification to attain potency, selectivity, and transgene-arming capacity in oncolytic adenoviruses","volume":"18","author":"Rojas","year":"2010","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.110_bib13","doi-asserted-by":"crossref","first-page":"6660","DOI":"10.1158\/0008-5472.CAN-04-1200","article-title":"Combination therapy with conditionally replicating adenovirus and replication defective adenovirus","volume":"64","author":"Lee","year":"2004","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2015.110_bib14","first-page":"3603","article-title":"Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors","volume":"62","author":"Studeny","year":"2002","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2015.110_bib15","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/bjh.12545","article-title":"Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid-refractory, grade III-IV acute graft-versus-host disease","volume":"163","author":"Ball","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1038\/mt.2015.110_bib16","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study","volume":"371","author":"Le Blanc","year":"2008","journal-title":"Lancet"},{"key":"10.1038\/mt.2015.110_bib17","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/sj.bmt.1703650","article-title":"Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH)","volume":"30","author":"Ko\u00e7","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1038\/mt.2015.110_bib18","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1016\/j.jacc.2009.06.055","article-title":"A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction","volume":"54","author":"Hare","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1038\/mt.2015.110_bib19","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1136\/ard.2009.123463","article-title":"Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study","volume":"69","author":"Liang","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1038\/mt.2015.110_bib20","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1158\/1535-7163.MCT-05-0334","article-title":"Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses","volume":"5","author":"Komarova","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1038\/mt.2015.110_bib21","doi-asserted-by":"crossref","first-page":"8932","DOI":"10.1158\/0008-5472.CAN-08-3873","article-title":"Human bone marrow-derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomas","volume":"69","author":"Yong","year":"2009","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2015.110_bib22","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1634\/stemcells.2007-0758","article-title":"Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma","volume":"26","author":"Sonabend","year":"2008","journal-title":"Stem Cells"},{"key":"10.1038\/mt.2015.110_bib23","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1089\/scd.2011.0643","article-title":"A specific subpopulation of mesenchymal stromal cell carriers overrides melanoma resistance to an oncolytic adenovirus","volume":"21","author":"Bolontrade","year":"2012","journal-title":"Stem Cells Dev"},{"key":"10.1038\/mt.2015.110_bib24","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/cgt.2009.67","article-title":"Reduction of nontarget infection and systemic toxicity by targeted delivery of conditionally replicating viruses transported in mesenchymal stem cells","volume":"17","author":"Dembinski","year":"2010","journal-title":"Cancer Gene Ther"},{"key":"10.1038\/mt.2015.110_bib25","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1089\/hum.2007.034","article-title":"Human mesenchymal stem cells lack tumor tropism but enhance the antitumor activity of oncolytic adenoviruses in orthotopic lung and breast tumors","volume":"18","author":"Hakkarainen","year":"2007","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2015.110_bib26","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1177\/00912700122010771","article-title":"Intravenous safety and pharmacokinetics of a novel dimerizer drug, AP1903, in healthy volunteers","volume":"41","author":"Iuliucci","year":"2001","journal-title":"J Clin Pharmacol"},{"key":"10.1038\/mt.2015.110_bib27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/mt.2011.159","article-title":"Adenovirus i-leader truncation bioselected against cancer-associated fibroblasts to overcome tumor stromal barriers","volume":"20","author":"Puig-Saus","year":"2012","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.110_bib28","series-title":"Fields Virology","article-title":"Adenoviruses","author":"Horvitz","year":"2001"},{"key":"10.1038\/mt.2015.110_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/mto.2014.8","article-title":"Combinatorial treatment with oncolytic adenovirus and helper-dependent adenovirus augments adenoviral cancer gene therapy","volume":"1","author":"Farzad","year":"2014","journal-title":"Mol Ther \u2013 Oncolytics"},{"key":"10.1038\/mt.2015.110_bib30","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1089\/104303403321618146","article-title":"The role of capsid-endothelial interactions in the innate immune response to adenovirus vectors","volume":"14","author":"Liu","year":"2003","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2015.110_bib31","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature06188","article-title":"Mesenchymal stem cells within tumour stroma promote breast cancer metastasis","volume":"449","author":"Karnoub","year":"2007","journal-title":"Nature"},{"key":"10.1038\/mt.2015.110_bib32","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/stem.433","article-title":"An inducible caspase 9 suicide gene to improve the safety of mesenchymal stromal cell therapies","volume":"28","author":"Ramos","year":"2010","journal-title":"Stem Cells"},{"key":"10.1038\/mt.2015.110_bib33","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1126\/science.1071059","article-title":"The danger model: a renewed sense of self","volume":"296","author":"Matzinger","year":"2002","journal-title":"Science"},{"key":"10.1038\/mt.2015.110_bib34","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.bbmt.2007.04.005","article-title":"Inducible caspase 9 suicide gene to improve the safety of allodepleted T cells after haploidentical stem cell transplantation","volume":"13","author":"Tey","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1038\/mt.2015.110_bib35","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1182\/blood-2004-11-4564","article-title":"An inducible caspase 9 safety switch for T-cell therapy","volume":"105","author":"Straathof","year":"2005","journal-title":"Blood"},{"key":"10.1038\/mt.2015.110_bib36","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1182\/blood-2006-04-017061","article-title":"T lymphocytes redirected against the kappa light chain of human immunoglobulin efficiently kill mature B lymphocyte-derived malignant cells","volume":"108","author":"Vera","year":"2006","journal-title":"Blood"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616302775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616302775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T17:58:44Z","timestamp":1537552724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616302775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S1525001616302775"],"URL":"https:\/\/doi.org\/10.1038\/mt.2015.110","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]}}}